Vedamurthy, M., & Humbert, P. (2018). A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma. International Journal of Research in Dermatology, 4(4), 471–478. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20184453